Ullman Quoted on FDA’s Targeting of CBD

January 17, 2020 | Compliance Investigations & White Collar | Cannabis

Marc Ullman was quoted in a Nutraingredients-USA story entitled “Warning letter analysis shows FDA has target on CBD, not hemp.”

To read the article, click here.

Share this article:

Related News

Get legal updates and news delivered to your inbox